Covid-19 roundup: EU looks to pre-order vaccines from Moderna, Sanofi, J&J, BioNTech, CureVac — report
The EU has reportedly locked down a final group of Covid-19 vaccine developers it wants to place advance purchases from.
Moderna, Sanofi, J&J, BioNTech and CureVac are all at the deal table, sources tell Reuters. The European Commission, which has a $2.7 billion rainy day fund earmarked for this purpose, confirmed to the news wire that it’s in talks with several companies but declined to name them.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,300+ biopharma pros reading Endpoints daily — and it's free.